Complimentary Webinar — Regulatory Submissions in Canada vs. the U.S
|
|
This webinar provides an overview of requirements for gaining approval to conduct a first-in-human (FIH) clinical trial via Health Canada’s Clinical Trial Authorization (CTA) process and the U.S. FDA’s Investigational New Drug (IND) submission process. Watch Altasciences’ Paul Sidney, Senior Director, Compliance and Regulatory Affairs, and Dr. Joe Francisco, Chief Toxicologist, as they provide insight as to how and why the conduct of FIH clinical trials in Canada may, in some cases, provide a more expedient method to gain human clinical safety data. |
|
|
Optimization of a Method for Radio-Telemetry Device Implantation
|
|
The methods used to surgically implant telemetry units to measure cardiovascular function and body temperature in nonhuman primates can impact the quality of the study information obtained. In a recent case study, Altasciences compared the quality of data capture of the standard intra-abdominal implant method versus a less invasive subcutaneous implant method. |
|
BioPharma Dive: Ligand Binding Program Considerations — The Value of Preclinical to Clinical Bioanalytical Expertise
Snuggle Wrap-based Restraint Method of Continuous Infusion in Juvenile Nonhuman Primates
Historical Control Database of Cynomolgus Macaque Spermatozoa
Determination of Normal: Flow Cytometry Analysis of Major Immune Cell Populations in Peripheral Blood of Naïve Cynomolgus Monkeys
Assessment of Subcutaneous Radio-Telepathy Device Implantation in Cynomolgus Monkeys
Assessment of Receptor Occupancy via Flow Cytometry: Benefits and Pitfalls of Two Common Approaches
Dedicated Full-Time Experts Working for You!
 |
|
At Altasciences, our full-time equivalent (FTE) solutions give you access to capabilities and expertise tailored to your requirements. Our experts treat your priorities with the same level of commitment to timelines and deliverables as you do. |
 |
 |